4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001507650-26-000007
Co-Chief Executive Officer bought 3,810,000 shares at $13.12 ($49,987,200)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-12 | Purchase : show line 1 in the form | +3,810,000 | $13.12 | $49,987,200 | 573,883,879 | I |
| Open-market purchases · 3,810,000 sh · avg $13.12 · $49,987,200 | ||||||
Loading xslF345X06/wk-form4_1781289308.xml…